Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact

Eur Arch Otorhinolaryngol. 2012 Dec;269(12):2555-60. doi: 10.1007/s00405-012-1941-7.

Abstract

To evaluate the prevalence of thyroid FDG-PET/CT incidentalomas and the risk of malignancy in focal findings. A retrospective study of 3,062 PET scans was performed between 05/2006 and 09/2009. Prevalence of thyroid incidentalomas, risk of malignancy and correlation between standard uptake value (SUV) and cancer risk were analysed. The overall prevalence of thyroid incidentalomas was 2.4%. 71% showed a focal and 29% a diffuse uptake. In the focal uptake group, the diagnosis was clarified in 79% with cytology/histology. In 23.8% of the patients with a focal uptake, a malignant lesion was found. Diffuse uptake was predominantly associated with autoimmune thyroiditis. There was no statistically significant difference in the SUVmax between benign and malignant focal lesions (p = 0.0982). Patients with incidental focal uptake in the thyroid during FDG-PET/CT bear a considerable risk of malignancy and should undergo cytologic clarification of the diagnosis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Diagnosis, Differential
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Incidental Findings*
  • Male
  • Middle Aged
  • Multimodal Imaging / statistics & numerical data*
  • Neoplasms / complications
  • Neoplasms / diagnostic imaging
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Retrospective Studies
  • Thyroid Diseases / complications
  • Thyroid Diseases / diagnostic imaging*
  • Thyroid Neoplasms / diagnostic imaging
  • Thyroid Nodule / diagnostic imaging
  • Thyroiditis, Autoimmune / diagnostic imaging
  • Tomography, X-Ray Computed*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18